Evidence map›Paper›PMID 31196719›Full record

ReviewEarly human development2019

To start or not: Factors to consider when implementing routine probiotic use in the NICU.

Maria E Barbian, Rachel Buckle, Patricia Wei Denning, Ravi Mangal Patel

Abstract readReview
In one paragraph

Review in Early human development, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Effects of prophylactic probiotics supplementation on infants born very preterm or very low birth weight.Journal of perinatology : official journal of the California Perinatal Association · 2023
    Article
  8. Article
  9. Review
  10. Current Status of Probiotics for Preterm Infants.Indian journal of pediatrics · 2021
    Review
  11. Frontiers in pediatrics · 2021
    Article
  12. Article
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Maria E BarbianDepartment of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States of America; Children's Healthcare of Atlanta, Atlanta, GA, United States of America.
Rachel BuckleDepartment of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States of America.
Patricia Wei DenningDepartment of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States of America; Children's Healthcare of Atlanta, Atlanta, GA, United States of America.
Ravi Mangal PatelDepartment of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States of America; Children's Healthcare of Atlanta, Atlanta, GA, United States of America. Electronic address: rmpatel@emory.edu.

Funding

Red Cell Transfusion, Severe Anemia and Necrotizing EnterocolitisK23HL128942 · NHLBI · EMORY UNIVERSITY · PI PATEL, RAVI MANGAL · 2016 to 2019
$665k
NHLBI NIH HHS K23 HL128942
6 · The paper itself

Abstract

Supplementation of probiotics to very low birth weight (VLBW) infants has been extensively studied, with multiple meta-analyses reporting probiotics decrease the risk of necrotizing enterocolitis (NEC) and death. Despite availability of this evidence, the decision to initiate routine probiotic supplementation to preterm infants continues to be a complex one. There are uncertainties regarding the use of probiotics, including selecting the appropriate product, dose and target population. Additionally, availability of specific probiotic products and regulatory oversight varies by country, raising concerns regarding the safety and efficacy of specific probiotic products. In this review, we summarize the latest evidence on probiotic use in preterm infants and discuss considerations that may help guide clinicians who are considering routine probiotic supplementation.

Indexed as

Infant, Very Low Birth WeightClinical Decision-MakingEnterocolitis, NecrotizingHumansInfant, NewbornIntensive Care, NeonatalProbioticsRandomized Controlled Trials as TopicInfantMicrobiomeNecrotizing enterocolitisNeonatePretermProbioticsSepsis

Identifiers

PMID31196719
PMCPMC6684237

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.